Back
ANI Pharmaceuticals Vs. Repligen Industry Stock Comparison
Buy
64
ANIP
ANI Pharmaceuticals
Last Price:
64.89
Seasonality Move:
-4.95%
Sell
43
RGEN
Repligen
Last Price:
127.68
Seasonality Move:
4.1%
Buy
64
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $64.19. The Score for ANIP is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $123.15. The Score for RGEN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $64.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing slight buying pressure.
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 52.35 | Buy |
| Chaikin Money Flow: | 49313 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.86 - 65.54) | Buy |
| Bollinger Bands (100): | (60.14 - 68.02) | Buy |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -10.58 | Sell |
| Relative Strength Index (14 RSI): | 26.78 | Sell |
| Chaikin Money Flow: | 404437 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (128.14 - 158.7) | Sell |
| Bollinger Bands (100): | (150.47 - 196.23) | Sell |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.65 | Buy |
| 20-day SMA: | 63.66 | Buy |
| 50-day SMA: | 64.48 | Sell |
| 200-day SMA: | 60.09 | Buy |
| 8-day EMA: | 62.26 | Buy |
| 20-day EMA: | 63.08 | Buy |
| 50-day EMA: | 63.89 | Buy |
| 200-day EMA: | 60 | Buy |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.88 | Sell |
| 20-day SMA: | 138.24 | Sell |
| 50-day SMA: | 154.6 | Sell |
| 200-day SMA: | 167.54 | Sell |
| 8-day EMA: | 126.51 | Sell |
| 20-day EMA: | 136.68 | Sell |
| 50-day EMA: | 151.89 | Sell |
| 200-day EMA: | 167.03 | Sell |
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.02 per share, and an increase next year of $0.61 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.28 per share, and an increase next year of $0.56 per share.
ANI Pharmaceuticals Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||